Copyright © Inderes 2011 - present. All rights reserved.
  • Uusimmat
  • Pörssi
    • Aamukatsaus
    • Osakevertailu
    • Pörssikalenteri
    • Osinkokalenteri
    • Analyysi
    • Artikkelit
    • Sisäpiirin kaupat
    • Transkriptit
  • inderesTV
  • Mallisalkku
  • Foorumi
  • Premium
  • Femme
  • Nora AI
  • Opi
    • Sijoituskoulu
    • Q&A
    • Analyysikoulu
  • Meistä
    • Seurantayhtiöt
    • Tiimi
Kolmannen osapuolen analyysi

Generic: The gross margin story remains strong - ABG

Generic Sweden

Tämä on kolmannen osapuolen analyysi, eikä välttämättä vastaa Inderesin näkemystä tai arvoja

Lataa raportti (PDF)
* Sales up 3% y-o-y, held back by soft volumes and tough comps
* We keep sales flat, and slightly raise opex
* Trading at 9-8x on '26e-'27e EV/EBITA, below its historical median


Recruiting and consulting costs weighing on EBIT

Generic reported an in-line Q4, with sales of SEK 49m, up 3% y-o-y, affected by softer volumes and tough comps. The gross margin came in at 44%, up from last year, indicating that SaaS continues to grow. Adj. EBIT decreased 4% y-o-y, primarily due to recruiting and consulting costs. It is also worth noting that Q4'24 was exceptionally strong. Looking at the full year, Generic grew adj. EBIT by 22% y-o-y. The DPS was proposed at SEK 1.75 (1.60 last year), and we note it has increased over the last 5 years, signalling earnings stability.


We raise opex by ~3%, but keep our view on scaling potential

We expect more top-line growth in 2026, as volumes should pick up, and as Generic continues to penetrate more customer groups. We raise operating costs slightly for '26e-'27e but keep our view of it reaching 22-23% EBIT margins, as we see potential for further scaling.


Volumes should pick up in 2026

Generic is currently trading at 9-8x '26e-'27e EV/EBITA, which is ~35% below its historical median. The messaging market has been impacted by pricing sensitivity, as customers in, e.g., logistics, have cut costs. However, churn remains low, and we believe volumes should pick up in 2026. DOCS continues to grow within municipalities, and Generic is starting to reposition the product as a document transfer product. This targets other customer segments, such as private healthcare companies and Swedish regions, and over time, this should scale and increase margins.
Sosiaalinen media
  • Inderes Foorumi
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Yhteystiedot
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Meistä
  • Tiimi
  • Avoimet työpaikat
  • Inderes sijoituskohteena
  • Palvelut pörssiyhtiöille
Sivusto
  • UKK
  • Käyttöehdot
  • Tietosuojaseloste
  • Vastuuvapauslauseke
Inderesin vastuuvapauslauseke löytyy täältä. Kunkin Inderesin aktiivisessa seurannassa olevan osakkeen tarkemmat tiedot löytyvät kunkin osakkeen omilta yhtiösivuilta Inderes-sivustolla. © Inderes Oyj. Kaikki oikeudet pidätetään.